The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study*

202169 citationsJournal Articlehybrid Open Access

Authors

In adult Chinese patients, dupilumab was effective in improving the signs and symptoms of AD and demonstrated a favourable safety profile.

Good health and well-being

Published in: British Journal of Dermatology

Volume 186, Issue 4, pp. 633-641

Field-Weighted Citation Impact: 8.65